Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04561440Unknown

Copy Number Variation in Prenatal Diagnosis

Role: lead

NCT03201666Unknown

Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies

Role: lead

NCT01574521Completed

Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)

Role: lead

NCT01537276Not ApplicableCompleted

Improve Hysterosalpingographic Accuracy by Real-time Fluoroscopy

Role: lead

All 4 trials loaded